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Objective
To simultaneously load drug and encapsulate the drug in a high throughput, massively-arrayed microfluidic
type system using a patented Chemtor fiber technology.
Motivation
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues
associated with conventional therapeutic agents, including their poor water solubility (at least, for most
anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic
index.
Trends in the development of 
nanomedicines
List of FDA-approved nanomedicines stratified by material 
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Polymer Nanoparticles – synthetic polymer particles combined with drugs or biologics 
Cimzia®/certolizumab
pegol (UCB) 
PEGylated antibody fragment 
(Certolizumab) 
Improved circulation time 

























(PEGylated factor VIII) 




Liposome formulations combined with drugs or biologics 
Marqibo® (Onco TCS) Liposomal Vincristine Increased delivery to tumour site; 






Onivyde® (Merrimack) Liposomal Irinotecan Increased delivery to tumour site; 





Micellar nanoparticles combined with drugs or biologics 




















Avinza® (Pfizer) Morphine sulfate Increased drug loading and 












Inorganic and metallic nanoparticles 
Nanotherm® 
(MagForce) 
Iron oxide Allows cell uptake and introduces 
Superparamagnetism
Glioblastoma 2010 
Delivery efficiency and consequences
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